ARTICLE | Company News
Ablynx, GlaxoSmithKline antibodies news
February 2, 2015 8:00 AM UTC
Ablynx said the Board of Appeal confirmed a 2010 decision from the Opposition Division of the European Patent Office (EPO) to revoke European Patent No. EP1517921 from GlaxoSmithKline’s Domantis Ltd....